阿托伐他汀通过抑制氧化应激和调节巨噬细胞极化改善db/db小鼠的心肌纤维化。
Atorvastatin ameliorated myocardial fibrosis in db/db mice by inhibiting oxidative stress and modulating macrophage polarization.
作者信息
Song Xian-Min, Zhao Meng-Nan, Li Gui-Zhi, Li Na, Wang Ting, Zhou Hong
机构信息
Department of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China.
Department of Geriatrics, Handan Central Hospital, Handan 056001, Hebei Province, China.
出版信息
World J Diabetes. 2023 Dec 15;14(12):1849-1861. doi: 10.4239/wjd.v14.i12.1849.
BACKGROUND
People with diabetes mellitus (DM) suffer from multiple chronic complications due to sustained hyperglycemia, especially diabetic cardiomyopathy (DCM). Oxidative stress and inflammatory cells play crucial roles in the occurrence and progression of myocardial remodeling. Macrophages polarize to two distinct phenotypes: M1 and M2, and such plasticity in phenotypes provide macrophages various biological functions.
AIM
To investigate the effect of atorvastatin on cardiac function of DCM in db/db mice and its underlying mechanisms.
METHODS
DCM mouse models were established and randomly divided into DM, atorvastatin, and metformin groups. C57BL/6 mice were used as the control. Cardiac function was evaluated by echocardiography. Hematoxylin and eosin and Masson staining was used to examine the morphology and collagen fibers in myocardial tissues. The expression of transforming growth factor-β1 (TGF-β1), tumor necrosis factor-α (TNF-α), interleukin-1 β (IL-1β),M1 macrophages (iNOS), and M2 macrophages (CD206) were demonstrated by immunohistochemistry and immunofluorescence staining. The levels of TGF-β1, IL-1β, and TNF-α were detected by ELISA and real-time quantitative polymerase chain reaction. Malondialdehyde (MDA) concentrations and superoxide dismutase (SOD) ac-tivities were also measured.
RESULTS
Treatment with atorvastatin alleviated cardiac dysfunction and decreased db/db mice. The broken myocardial fibers and deposition of collagen in the myocardial interstitium were relieved especially by atorvastatin treatment. Atorvastatin also reduced the levels of serum lactate dehydrogenase, creatine kinase isoenzyme, and troponin; lowered the levels of TGF-β1, TNF-α and IL-1β in serum and myocardium; decreased the concentration of MDA and increased SOD activity in myocardium of db/db mice; inhibited M1 macrophages; and promoted M2 macrophages.
CONCLUSION
Administration of atorvastatin attenuates myocardial fibrosis in db/db mice, which may be associated with the antioxidative stress and anti-inflammatory effects of atorvastatin on diabetic myocardium through modulating macrophage polarization.
背景
糖尿病患者因持续性高血糖会出现多种慢性并发症,尤其是糖尿病性心肌病(DCM)。氧化应激和炎症细胞在心肌重塑的发生和发展中起关键作用。巨噬细胞可极化为两种不同的表型:M1和M2,这种表型可塑性赋予巨噬细胞多种生物学功能。
目的
研究阿托伐他汀对db/db小鼠DCM心脏功能的影响及其潜在机制。
方法
建立DCM小鼠模型并随机分为糖尿病组、阿托伐他汀组和二甲双胍组。以C57BL/6小鼠作为对照。通过超声心动图评估心脏功能。采用苏木精-伊红染色和Masson染色观察心肌组织的形态和胶原纤维。通过免疫组织化学和免疫荧光染色检测转化生长因子-β1(TGF-β1)、肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、M1巨噬细胞(诱导型一氧化氮合酶)和M2巨噬细胞(CD206)的表达。采用酶联免疫吸附测定法和实时定量聚合酶链反应检测TGF-β1、IL-1β和TNF-α的水平。同时测定丙二醛(MDA)浓度和超氧化物歧化酶(SOD)活性。
结果
阿托伐他汀治疗可改善db/db小鼠的心脏功能障碍并减轻心肌损伤。特别是阿托伐他汀治疗可减轻心肌纤维断裂和心肌间质胶原沉积。阿托伐他汀还降低了血清乳酸脱氢酶、肌酸激酶同工酶和肌钙蛋白水平;降低了血清和心肌中TGF-β1、TNF-α和IL-1β的水平;降低了db/db小鼠心肌中MDA浓度并提高了SOD活性;抑制了M1巨噬细胞;并促进了M2巨噬细胞。
结论
给予阿托伐他汀可减轻db/db小鼠的心肌纤维化,这可能与阿托伐他汀通过调节巨噬细胞极化对糖尿病心肌的抗氧化应激和抗炎作用有关。